Abstract
Functional parkinsonism is defined by the presence of a combination of marked slowness of movement in the absence of progressive decrement and variable resistance against passive movement, that is not caused by neurodegeneration or specific dysfunction of the dopaminergic system. Functional tremor and functional gait impairment may also be present. Functional parkinsonism is estimated to represent between 3% and 6% of patients with functional movement disorder. Functional parkinsonism should be considered if a patient exhibits sudden onset of symptoms with maximal severity at onset, and if there is no improvement with dopaminergic therapy. Clinical signs suggesting a functional neurological origin include distractibility, tremor entrainment, oppositional stiffness without cogwheel rigidity, and bradykinesia without decreased amplitude. Complementary exams, such as a DaTscan, can be used as adjunctive tools in the evaluation of functional parkinsonism, and be useful in providing evidence either for or against a comorbid neurodegenerative parkinsonism (in the case of a positive or negative scan, respectively). Treatment of functional parkinsonism should involve a multidisciplinary team including neurologists and psychiatrists and may include TMS, physical therapy, and psychotherapy.
All authors have contributed to and approved the submitted draft manuscript.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wissel BD, et al. Functional neurological disorders in Parkinson disease. J Neurol Neurosurg Psychiatry. 2018;89(6):566–71. https://doi.org/10.1136/jnnp-2017-317378.
Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol. 1988;50:431–55.
Gupta A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol. 2009;22(4):430–6. https://doi.org/10.1097/WCO.0b013e32832dc169.
Ambar Akkaoui M, Geoffroy PA, Roze E, Degos B, Garcin B. Functional motor symptoms in Parkinson’s disease and functional parkinsonism: a systematic review. J Neuropsychiatry Clin Neurosci. 2020;32:4–13. https://doi.org/10.1176/appi.neuropsych.19030058.
Walters AS, Wright D, Boudwin J, Jones K. Three hysterical movement disorders. Psychol Rep. 1988;62(3):979–85. https://doi.org/10.2466/pr0.1988.62.3.979.
Lang AE, Koller WC, Fahn S. Psychogenic parkinsonism. Arch Neurol. 1995;52(8):802–10. https://doi.org/10.1001/archneur.1995.00540320078015.
Jankovic J. Diagnosis and treatment of psychogenic parkinsonism. J Neurol Neurosurg Psychiatry. 2011;82(12):1300–3. https://doi.org/10.1136/jnnp-2011-300876.
Frasca Polara G, et al. Prevalence of functional (psychogenic) parkinsonism in two Swiss movement disorders clinics and review of the literature. J Neurol Sci. 2018;387:37–45. https://doi.org/10.1016/j.jns.2018.01.022.
Sage JI, Mark MH. Psychogenic parkinsonism: clinical spectrum and diagnosis. Ann Clin Psychiatry. 2015;27(1):33–8.
Onofrj M, et al. Updates on somatoform disorders (SFMD) in Parkinson’s disease and dementia with Lewy bodies and discussion of phenomenology. J Neurol Sci. 2011;310(1–2):166–71. https://doi.org/10.1016/j.jns.2011.07.010.
Stone J, et al. Which neurological diseases are most likely to be associated with “symptoms unexplained by organic disease”. J Neurol. 2012;259(1):33–8. https://doi.org/10.1007/s00415-011-6111-0.
Umeh CC, Szabo Z, Pontone GM, Mari Z. Dopamine transporter imaging in psychogenic parkinsonism and neurodegenerative parkinsonism with psychogenic overlay: a report of three cases. Tremor Other Hyperkinet Mov (N Y). 2013;3:4.
Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry. 1995;59(4):406–12. https://doi.org/10.1136/jnnp.59.4.406.
Bonnet C, Mesrati F, Roze E, Hubsch C, Degos B. Motor and non-motor symptoms in functional parkinsonism responsive to transcranial magnetic stimulation: a case report. J Neurol. 2016;263(4):816–7. https://doi.org/10.1007/s00415-016-8061-z.
Pourfar MH, Tang CC, Mogilner AY, Dhawan V, Eidelberg D. Using imaging to identify psychogenic parkinsonism before deep brain stimulation surgery: report of 2 cases. J Neurosurg. 2012;116(1):114–8. https://doi.org/10.3171/2011.10.JNS11554.
Kumar R, Kumar R. A case of psychogenic Parkinsonism: late age of onset should not be a barrier to make the diagnosis. Aust N Z J Psychiatry. 2018;52(11):1098. https://doi.org/10.1177/0004867418804068.
Langevin J-P, Skoch JM, Sherman SJ. Deep brain stimulation of a patient with psychogenic movement disorder. Surg Neurol Int. 2016;7(Suppl 35):S824–6. https://doi.org/10.4103/2152-7806.194063.
Gaig C, et al. 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism. Mov Disord. 2006;21(11):1994–8. https://doi.org/10.1002/mds.21062.
Benaderette S, et al. Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [123I]-FP-CIT SPECT scan explorations improves diagnostic accuracy. Mov Disord. 2006;21(3):310–7. https://doi.org/10.1002/mds.20720.
Park JE, Maurer CW, Hallett M. The “whack-a-mole” sign in functional movement disorders. Mov Disord Clin Pract. 2015;2(3):286–8. https://doi.org/10.1002/mdc3.12177.
Deuschl G, Köster B, Lücking CH, Scheidt C. Diagnostic and pathophysiological aspects of psychogenic tremors. Mov Disord. 1998;13(2):294–302. https://doi.org/10.1002/mds.870130216.
Thenganatt MA, Jankovic J. Psychogenic (functional) parkinsonism. In: Handbook of clinical neurology, vol. 139. Elsevier; 2016. p. 259–62.
Okun MS, Rodriguez RL, Foote KD, Fernandez HH. The “chair test” to aid in the diagnosis of psychogenic gait disorders. Neurologist. 2007;13(2):87–91. https://doi.org/10.1097/01.nrl.0000256358.52613.cc.
Felicio AC, et al. Degenerative parkinsonism in patients with psychogenic parkinsonism: a dopamine transporter imaging study. Clin Neurol Neurosurg. 2010;112(4):282–5. https://doi.org/10.1016/j.clineuro.2009.12.010.
Ba F, Martin WRW. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice. Parkinsonism Relat Disord. 2015;21(2):87–94. https://doi.org/10.1016/j.parkreldis.2014.11.007.
Rodriguez-Porcel F, Jamali S, Duker AP, Espay AJ. Dopamine transporter scanning in the evaluation of patients with suspected Parkinsonism: a case-based user’s guide. Expert Rev Neurother. 2016;16(1):23–9. https://doi.org/10.1586/14737175.2015.1120160.
Nicastro N, Burkhard PR, Garibotto V. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: a prospective study. J Neurol Sci. 2018;385:17–21. https://doi.org/10.1016/j.jns.2017.11.039.
Vial F, Kassavetis P, Merchant S, Haubenberger D, Hallett M. How to do an electrophysiological study of tremor. Clin Neurophysiol Pract. 2019;4:134–42. https://doi.org/10.1016/j.cnp.2019.06.002.
Schwingenschuh P, et al. Validation of “laboratory-supported” criteria for functional (psychogenic) tremor. Mov Disord. 2016;31(4):555–62. https://doi.org/10.1002/mds.26525.
Lidstone SC, et al. Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry. 2010;67(8):857–65. https://doi.org/10.1001/archgenpsychiatry.2010.88.
Stone J, Edwards M. Trick or treat?: Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology. 2012;79(3):282–4. https://doi.org/10.1212/WNL.0b013e31825fdf63.
Aybek S, Hubschmid M, Mossinger C, Berney A, Vingerhoets F. Early intervention for conversion disorder: neurologists and psychiatrists working together. Acta Neuropsychiatr. 2013;25(1):52–6. https://doi.org/10.1111/j.1601-5215.2012.00668.x.
Hubschmid M, et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. Gen Hosp Psychiatry. 2015;37(5):448–55. https://doi.org/10.1016/j.genhosppsych.2015.05.007.
Stone J, Carson A, Hallett M. Explanation as treatment for functional neurologic disorders. Handb Clin Neurol. 2016;139:543–53. https://doi.org/10.1016/B978-0-12-801772-2.00044-8.
Nielsen G, Stone J, Edwards MJ. Physiotherapy for functional (psychogenic) motor symptoms: a systematic review. J Psychosom Res. 2013;75(2):93–102. https://doi.org/10.1016/j.jpsychores.2013.05.006.
Kompoliti K, Wilson B, Stebbins G, Bernard B, Hinson V. Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial. Parkinsonism Relat Disord. 2014;20(1):60–3. https://doi.org/10.1016/j.parkreldis.2013.09.018.
Reuber M, Burness C, Howlett S, Brazier J, Grünewald R. Tailored psychotherapy for patients with functional neurological symptoms: a pilot study. J Psychosom Res. 2007;63(6):625–32. https://doi.org/10.1016/j.jpsychores.2007.06.013.
Hinson VK, Weinstein S, Bernard B, Leurgans SE, Goetz CG. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord. 2006;12(3):177–80. https://doi.org/10.1016/j.parkreldis.2005.10.006.
Sharpe M, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology. 2011;77(6):564–72. https://doi.org/10.1212/WNL.0b013e318228c0c7.
Dallocchio C, Tinazzi M, Bombieri F, Arnó N, Erro R. Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychother Psychosom. 2016;85(6):381–3. https://doi.org/10.1159/000446660.
Garcin B, et al. Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders. J Neurol Neurosurg Psychiatry. 2013;84(9):1043–6. https://doi.org/10.1136/jnnp-2012-304062.
Garcin B, et al. Impact of transcranial magnetic stimulation on functional movement disorders: cortical modulation or a behavioral effect? Front Neurol. 2017;8:338. https://doi.org/10.3389/fneur.2017.00338.
McWhirter L, Carson A, Stone J. The body electric: a long view of electrical therapy for functional neurological disorders. Brain J Neurol. 2015;138(Pt 4):1113–20. https://doi.org/10.1093/brain/awv009.
Conflict of Interest Statements:
Marine Ambar Akkaoui and Béatrice Garcin declare no conflicts of interest. Bertrand Degos received honoraria from IPSEN and travel funding from Merz-Pharma, Elivie, Orkyn.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Electronic Supplementary Material
Vignette 1: In the first scene (1), there is a diminished arm swing on the right, which persists while running. There is a postural tremor of the right hand during the walk. There is no slowness of the gait and no freezing. The second sequence (2) shows tremor distractibility, with cessation of the right hand tremor when the patient concentrates on tapping with the left hand. The tremor of the right hand then tends to adopt the frequency of the left hand tapping, a phenomenon referred to as entrainability. In the third sequence (3), we see slow movements of the right hand, without gradual decrement in amplitude. In the last sequence (4), the patient exhibits choreiform-like movements of the upper and lower limbs (MP4 330846 kb)
Vignette 2: The first sequence (1) shows the evaluation of akinesia in the upper and lower limbs. Movements of both the upper and lower limbs are slow, without gradual decrement in amplitude. The second scene (2) demonstrates assessment of motor tone. Rigidity that is initially observed in the left arm is found to decrease with reinforcement maneuver. The third sequence (3) shows a Hoover’s sign of left leg, with an initial deficit of left hip extension, but normal left hip extension during right hip flexion. There is no fall on the pull test (4). The patient exhibits slow gait, without freezing. There is diminished arm swing of both arms (5) (MP4 98902 kb)
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Akkaoui, M.A., Degos, B., Garcin, B. (2022). Functional Parkinsonism. In: LaFaver, K., Maurer, C.W., Nicholson, T.R., Perez, D.L. (eds) Functional Movement Disorder. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-030-86495-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-86495-8_8
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-86494-1
Online ISBN: 978-3-030-86495-8
eBook Packages: MedicineMedicine (R0)